Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Glycaemic variability in diabetes: clinical and therapeutic implications

Abstract : Glycaemic variability is an integral component of glucose homoeostasis. Although it has not yet been definitively confirmed as an independent risk factor for diabetes complications, glycaemic variability can represent the presence of excess glycaemic excursions and, consequently, the risk of hyperglycaemia or hypoglycaemia. Glycaemic variability is currently defined by a large and increasing number of metrics, representing either short-term (within-day and between-day variability) or long-term glycaemic variability, which is usually based on serial measurements of HbA1c or other measures of glycaemia over a longer period of time. In this Review, we discuss recent evidence examining the association between glycaemic variability and diabetes-related complications, as well as non-pharmacological and pharmacological strategies currently available to address this challenging aspect of diabetes management.
Liste complète des métadonnées
Contributeur : Amandine Michel-Avella <>
Soumis le : vendredi 24 avril 2020 - 11:45:39
Dernière modification le : vendredi 15 mai 2020 - 12:22:05

Lien texte intégral




Antonio Ceriello, Louis Monnier, David Owens. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes and Endocrinology , Elsevier, 2019, 7 (3), pp.221-230. ⟨10.1016/S2213-8587(18)30136-0⟩. ⟨hal-02553264⟩



Consultations de la notice